← Back to headlines
India's cheap weight-loss drugs could reshape global obesity fight
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
18 Mar, 00:30 — 18 Mar, 00:30
Sources
Showing 1 of 1 sources
Related Stories
Irish Health Agency Fined €645,000 for Storing Records in Derelict Sites
2h ago
New Urine Test Detects Over 90 Percent of Bladder Cancer Cases
2h ago
Swimmer Hospitalized Following Suspected Shark Attack in Massachusetts
6h ago
Wellington Clinics Suspends Kidney Transplants Amid Organ Harvesting Probe
11h ago